Pharmacokinetics and Glucodynamics of Ultra Rapid Lispro (URLi) versus Humalog(®) (Lispro) in Patients with Type 2 Diabetes Mellitus: A Phase I Randomised, Crossover Study

BACKGROUND AND OBJECTIVE: Ultra rapid lispro (URLi) is a novel insulin lispro formulation developed to more closely match physiological insulin secretion and improve postprandial glucose control. This study compared the insulin lispro pharmacokinetics and glucodynamics, safety and tolerability of UR...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Clin Pharmacokinet
Main Authors: Leohr, Jennifer, Dellva, Mary Anne, Coutant, David E., LaBell, Elizabeth, Heise, Tim, Andersen, Grit, Zijlstra, Eric, Hermanski, Lidia, Nosek, Leszek, Linnebjerg, Helle
Format: Artigo
Jezik:Inglês
Izdano: Springer International Publishing 2020
Teme:
Original Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7716902/
https://ncbi.nlm.nih.gov/pubmed/32468448
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40262-020-00901-2
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki